U.S. markets closed

Accelerate Diagnostics, Inc. (AXDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.23+0.45 (+5.13%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
11,526
9,297
5,670
4,177
Cost of Revenue
6,702
4,897
3,187
1,002
Gross Profit
4,824
4,400
2,483
3,175
Operating Expense
71,713
77,231
82,852
67,359
Operating Income
-66,889
-72,831
-80,369
-64,184
Net Non Operating Interest Income Expense
-13,978
-11,447
-7,268
908
Other Income Expense
125
-138
-478
-259
Pretax Income
-80,742
-84,416
-88,115
-63,535
Tax Provision
-111
-111
211
493
Net Income Common Stockholders
-80,631
-84,305
-88,326
-64,028
Diluted NI Available to Com Stockholders
-80,631
-84,305
-88,326
-64,028
Basic EPS
-
-0.0016
-0.0016
-0.0012
Diluted EPS
-
-0.0016
-0.0016
-0.0012
Basic Average Shares
-
54,506
54,494
54,073
Diluted Average Shares
-
54,506
54,494
54,073
Total Operating Income as Reported
-66,889
-72,831
-80,369
-64,184
Total Expenses
78,415
82,128
86,039
68,361
Net Income from Continuing & Discontinued Operation
-80,631
-84,305
-88,326
-64,028
Normalized Income
-80,840
-84,181
-87,997
-63,983
Interest Income
1,233
2,809
2,845
908
Interest Expense
15,211
14,256
10,113
0
Net Interest Income
-13,978
-11,447
-7,268
908
EBIT
-65,531
-70,160
-78,002
-63,535
EBITDA
-62,521
-
-
-
Reconciled Cost of Revenue
6,702
4,897
3,187
1,002
Reconciled Depreciation
3,010
2,602
2,561
2,196
Net Income from Continuing Operation Net Minority Interest
-80,631
-84,305
-88,326
-64,028
Total Unusual Items Excluding Goodwill
209
-124
-450
-75
Total Unusual Items
209
-124
-450
-75
Normalized EBITDA
-62,730
-67,434
-74,991
-61,264
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0.2873
-0.1612
-121.5
-30